Larvol Delta - Opthea-Data-for-OPT302-in-Patients-with-Polypoidal-Choroidal-Vasculopathy-PCV-Presented-at-Angiogenesis-2022

OPT-302 - Opthea

Lucentis (ranibizumab) - Roche, Novartis

https://www.globenewswire.com/news-release/2022/02/14/2384195/0/en/Opthea-Data-for-OPT-302-in-Patients-with-Polypoidal-Choroidal-Vasculopathy-PCV-Presented-at-Angiogenesis-2022.html

Feb 14, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next